Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,507 INR | +0.80% | -0.30% | +19.62% |
Sales 2024 * | 485B 5.81B | Sales 2025 * | 538B 6.45B | Capitalization | 3,615B 43.29B |
---|---|---|---|---|---|
Net income 2024 * | 93.04B 1.11B | Net income 2025 * | 113B 1.35B | EV / Sales 2024 * | 7.25 x |
Net cash position 2024 * | 97.98B 1.17B | Net cash position 2025 * | 161B 1.93B | EV / Sales 2025 * | 6.41 x |
P/E ratio 2024 * |
38.5
x | P/E ratio 2025 * |
32
x | Employees | 41,000 |
Yield 2024 * |
0.82% | Yield 2025 * |
0.95% | Free-Float | 45.31% |
Latest transcript on Sun Pharmaceutical Industries Ltd.
1 day | +0.80% | ||
1 week | -0.30% | ||
Current month | +0.30% | ||
1 month | -6.08% | ||
3 months | -1.82% | ||
6 months | +27.74% | ||
Current year | +19.62% |
Managers | Title | Age | Since |
---|---|---|---|
Aalok Shanghvi
CEO | Chief Executive Officer | - | - |
Founder | 68 | 81-12-31 | |
Director of Finance/CFO | - | 17-06-18 |
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | 68 | 81-12-31 | |
Rama Bijapurkar
BRD | Director/Board Member | 67 | 21-05-20 |
Rolf K. Hoffmann
BRD | Director/Board Member | 64 | 23-06-14 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.72% | 6 M€ | +6.07% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 1,507 | +0.80% | 1,528,487 |
24-05-09 | 1,495 | -1.78% | 1,477,007 |
24-05-08 | 1,522 | +0.42% | 1,026,357 |
24-05-07 | 1,515 | -0.90% | 1,532,550 |
24-05-06 | 1,529 | +1.19% | 1,240,626 |
Delayed Quote NSE India S.E., May 10, 2024 at 07:43 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.62% | 43.27B | |
+24.52% | 22.92B | |
+20.29% | 15.43B | |
+7.48% | 12.95B | |
+42.51% | 11.83B | |
-8.84% | 6.91B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+13.13% | 5.55B | |
+9.14% | 4.9B |
- Stock Market
- Equities
- SUNPHARMA Stock